ICCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
IceCure Medical Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 17, 2026
$1.08+0.02 (+1.89%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 4.5
- Dividend yield
- –
Ownership
Who owns IceCure Medical's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Mr. Li Haixiang | 35,846,597 | 45.80% | 13D (active) amendment | Mar 17, 2026 |
| Armistice Capital, LLC | 300,332 | 9.99% | 13G (passive) | Jun 30, 2026 |
| Epoch Partner Investments Limited | 25,846,597 | 52.20% | 13G (passive) amendment | Sep 30, 2024 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Eyal Shamir | Chief Executive Officer, Director | 791,381 | 1.08% | Mar 25, 2026 |
| Meir Peleg | Chief Financial Officer | 194,816 | 0.27% | Aug 17, 2026 |
| Shay Levav | Chief Operating Officer | 146,303 | 0.20% | Aug 17, 2026 |
| Shad Good | VP, Sales for North America | 136,698 | 0.19% | Aug 17, 2026 |
| Merav Nir Dotan | VP, Human Resources | 76,168 | 0.10% | Aug 17, 2026 |
| Tlalit Bussi Tel-Tzure | VP, BD & Global Marketing | 106,518 | 0.15% | Aug 17, 2026 |
| Naum Muchnik | VP, R&D & Engineering | 118,621 | 0.16% | May 18, 2026 |
| Ronen Tsimerman | Chief Financial Officer | 177,949 | 0.24% | May 18, 2026 |
| David Salton | Director | – | – | Aug 17, 2026 |
| Vincent Chun Hung Chan | Director | – | – | Aug 17, 2026 |
| Sharon Levita | Director | – | – | Mar 25, 2026 |
| Yonatan Malca | Director | – | – | Mar 25, 2026 |
| Ron Mayron | Director | 296,631 | 0.41% | Mar 25, 2026 |
| Yang Huang | Director | 111,468 | 0.15% | Mar 25, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Meir Peleg Chief Financial Officer | Aug 14, 2026 | Award | +181,483 | – | – | 194,816 |
| Tlalit Bussi Tel-Tzure VP, BD & Global Marketing | Aug 14, 2026 | Award | +101,483 | – | – | 106,518 |
| Shay Levav Chief Operating Officer | Aug 14, 2026 | Award | +141,483 | – | – | 146,303 |
| Shad Good VP, Sales for North America | Aug 14, 2026 | Award | +131,483 | – | – | 136,698 |
| Merav Nir Dotan VP, Human Resources | Aug 14, 2026 | Award | +73,890 | – | – | 76,168 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.